CPRIT Releases Four Product Development Research Funding Opportunities (Cycle 23.1 RFAs)

CPRIT announces the release of four (4) Requests for Applications (RFAs) for FY 2023 Product Development Research grants. Complete RFAs and instructions are available in the “Apply for Funding” section of CPRIT’s website.

•    Texas Therapeutics Company Product Development Research Award (TTC)
•    Texas Diagnostics and Devices Company Product Development Research Award (TDDC)
•    Texas New Technologies Company Product Development Research Award (TNTC)
•    Seed Awards for Product Development Research (SEED)

CPRIT Oversight Committee approves over $89 million in grants

(AUSTIN) Today, in a meeting at the State Capitol, the Oversight Committee of the Cancer Prevention and Research Institute of Texas (CPRIT), approved a large slate of awards totaling over $89 million for cancer research, prevention and product development. The list of grants is included below.

“The awards approved today by the Oversight Committee illustrate the depth and breadth of CPRIT's impact in the Texas fight against cancer,” said CPRIT CEO Wayne Roberts. “From recruitment grants bringing the brightest cancer researchers to Texas, to supporting lifesaving prevention programs across the state and providing critical investments in developing new cancer-fighting drugs, CPRIT touched all the bases for a home run against cancer.”

CPRIT CEO Roberts Endorses Bertagnolli NCI Appointment

Last week, President Biden nominated Dr. Monica Bertagnolli to lead the National Cancer Institute. An accomplished surgical oncologist and scientist, Dr. Bertagnolli is the first woman to hold this post.

As NCI and CPRIT are the top two public funders of cancer research in the world, CPRIT CEO Wayne Roberts has sent the White House an official letter to add his voice to those supporting Dr. Bertagnolli's nomination.  

View Letter Here (PDF)

CPRIT Product Development Program Applications for FY 2023 Awards

At its meeting on May 18, 2022, CPRIT’s Oversight Committee approved four FY 2023 requests for applications (RFAs) for the Product Development Research program.  The Oversight Committee also approved changes to the product development application and review process for the FY 2023 review cycle. 

The Texas Comptroller’s Office is currently reviewing the proposed Product Development Program RFAs.  CPRIT will release the RFAs after the Comptroller’s review, which we expect to occur in July.  CPRIT staff plan to open the portal to receive preliminary applications in August. (more)

Notice Regarding FY22 and FY23 Academic Research Program Budget

CPRIT’s Academic Research Program received an unprecedented number of high-quality applications over the past nine months (September 2021-May 2022) and awarded more Individual Investigator Research Awards (IIRAs) and Recruitment Scholar Awards in February and May than in previous years (40% more IIRAs and 20% more Recruitment Awards). 

CPRIT Oversight Committee approves almost $48 million in recruitment grants

(AUSTIN) Today, the Oversight Committee, the governing body of the Cancer Prevention and Research Institute of Texas (CPRIT), has approved a slate of 17 recruitment awards for a total of almost $48 million, bringing eminent cancer researchers from across the country to Texas institutions.